Dianthus Therapeutics, Inc. /DE/ (DNTH) — Institutional Holders, Q2 2026
272 institutional investment managers reported a DNTH position on SEC Form 13F-HR for the quarter ended June 30, 2026, with a combined reported value of $6.4B. Every filer is listed below, ranked by position value, 100 per page; this page shows ranks 1 to 100. Put and call option positions are excluded, and a firm filing several lots or share classes is shown once with its total.
DNTH in Q2 2026: what funds did
Funds that filed a 13F for both Q1 2026 and Q2 2026, by what they did with the common stock. Share counts are adjusted for any split between the two quarters; dollar figures are the change in shares at this quarter’s price.
Biggest buyers
- T. Rowe Price Investment ManagementAdded · +2,596,274 sh+$253.1M
- PRICE T ROWE ASSOCIATESAdded · +1,367,998 sh+$133.4M
- STATE STREETAdded · +958,527 sh+$93.4M
- BlackRockAdded · +948,119 sh+$92.4M
- WELLINGTON MANAGEMENT GROUP LLPAdded · +634,099 sh+$61.8M
Biggest sellers
- RA CAPITAL MANAGEMENT, L.P.Sold out · -2,611,733 sh-$254.6M
- FARALLON CAPITAL MANAGEMENTSold out · -836,000 sh-$81.5M
- Point72 Asset Management, L.P.Sold out · -643,599 sh-$62.7M
- CITADEL ADVISORSTrimmed · -635,572 sh-$62.0M
- Catalio Capital ManagementTrimmed · -527,367 sh-$51.4M
DNTH 13F holders ranked 1–100 of 272
| # | Institution | Shares | Value | % of portfolio | QoQShares vs Q1 2026 |
|---|---|---|---|---|---|
| 1 | FMR#1 · 8,199,893 sh | 8,199,893 | $799.3M | 0.03% | +5.6% |
| 2 | BlackRock#2 · 4,123,822 sh | 4,123,822 | $402.0M | <0.01% | +29.9% |
| 3 | T. Rowe Price Investment Management#3 · 3,888,456 sh | 3,888,456 | $379.0M | 0.25% | +200.9% |
| 4 | WELLINGTON MANAGEMENT GROUP LLP#4 · 3,229,882 sh | 3,229,882 | $314.8M | 0.05% | +24.4% |
| 5 | Fairmount Funds Management#5 · 2,537,191 sh | 2,537,191 | $247.3M | 16.35% | 0.0% |
| 6 | PRICE T ROWE ASSOCIATES#6 · 2,514,946 sh | 2,514,946 | $245.2M | 0.02% | +119.3% |
| 7 | STATE STREET#7 · 2,357,440 sh | 2,357,440 | $229.8M | <0.01% | +68.5% |
| 8 | VANGUARD CAPITAL MANAGEMENT#8 · 2,159,568 sh | 2,159,568 | $210.5M | <0.01% | +6.3% |
| 9 | Avidity Partners Management#9 · 2,104,184 sh | 2,104,184 | $205.1M | 32.85% | 0.0% |
| 10 | Octagon Capital Advisors#10 · 1,841,667 sh | 1,841,667 | $179.5M | 16.14% | -5.4% |
| 11 | TCG Crossover Management#11 · 1,676,624 sh | 1,676,624 | $163.4M | 3.93% | 0.0% |
| 12 | FRED ALGER MANAGEMENT#12 · 1,302,493 sh | 1,302,493 | $127.0M | 0.42% | +12.1% |
| 13 | GEODE CAPITAL MANAGEMENT#13 · 1,258,502 sh | 1,258,502 | $122.7M | <0.01% | +37.4% |
| 14 | VR Adviser#14 · 1,180,000 sh | 1,180,000 | $115.0M | 3.49% | 0.0% |
| 15 | UBS Group AG#15 · 1,140,260 sh | 1,140,260 | $111.2M | 0.01% | +45.9% |
| 16 | DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)#16 · 1,125,313 sh | 1,125,313 | $109.7M | 1.14% | +10.3% |
| 17 | JENNISON ASSOCIATES#17 · 1,021,763 sh | 1,021,763 | $99.6M | 0.06% | +110.6% |
| 18 | Polar Capital Plc#18 · 1,018,726 sh | 1,018,726 | $99.3M | 0.23% | -5.3% |
| 19 | CITADEL ADVISORS#19 · 974,911 sh | 974,911 | $95.0M | 0.01% | -39.5% |
| 20 | FRANKLIN RESOURCES#20 · 968,983 sh | 968,983 | $94.5M | 0.02% | +0.1% |
| 21 | BAKER BROS. ADVISORS#21 · 852,164 sh | 852,164 | $83.1M | 0.42% | 0.0% |
| 22 | Logos Global Management#22 · 800,000 sh | 800,000 | $78.0M | 3.36% | +100.0% |
| 23 | Cormorant Asset Management#23 · 750,000 sh | 750,000 | $73.1M | 3.75% | -21.1% |
| 24 | ALLIANCEBERNSTEIN L.P.#24 · 834,150 sh | 834,150 | $70.0M | 0.02% | -9.9% |
| 25 | BRAIDWELL#25 · 594,562 sh | 594,562 | $58.0M | 2.14% | -33.9% |
| 26 | VANGUARD PORTFOLIO MANAGEMENT#26 · 570,115 sh | 570,115 | $55.6M | <0.01% | +63.2% |
| 27 | AMERIPRISE FINANCIAL#27 · 531,999 sh | 531,999 | $51.9M | 0.01% | +48.4% |
| 28 | Woodline Partners#28 · 500,548 sh | 500,548 | $48.8M | 0.15% | +15.5% |
| 29 | BARCLAYS PLC#29 · 431,753 sh | 431,753 | $42.1M | <0.01% | +13.7% |
| 30 | LORD, ABBETT#30 · 422,185 sh | 422,185 | $41.2M | 0.12% | +41.1% |
| 31 | MPM BioImpact#31 · 420,002 sh | 420,002 | $40.9M | 2.50% | -0.9% |
| 32 | NORTHERN#32 · 411,791 sh | 411,791 | $40.1M | <0.01% | +35.6% |
| 33 | Affinity Asset Advisors#33 · 400,000 sh | 400,000 | $39.0M | 1.76% | +14.3% |
| 34 | SILVERARC CAPITAL MANAGEMENT#34 · 390,000 sh | 390,000 | $38.0M | 3.95% | -40.4% |
| 35 | GOLDMAN SACHS GROUP#35 · 382,161 sh | 382,161 | $37.3M | <0.01% | -30.3% |
| 36 | CHARLES SCHWAB INVESTMENT MANAGEMENT#36 · 365,963 sh | 365,963 | $35.7M | <0.01% | +19.8% |
| 37 | Bain Capital Life Sciences Investors#37 · 362,470 sh | 362,470 | $35.3M | 2.10% | 0.0% |
| 38 | Spruce Street Capital#38 · 354,816 sh | 354,816 | $34.6M | 6.79% | -4.9% |
| 39 | Vivo Capital#39 · 353,998 sh | 353,998 | $34.5M | 3.15% | 0.0% |
| 40 | DIMENSIONAL FUND ADVISORS#40 · 321,503 sh | 321,503 | $31.3M | <0.01% | -1.2% |
| 41 | WESTFIELD CAPITAL MANAGEMENT#41 · 314,914 sh | 314,914 | $30.7M | 0.10% | New |
| 42 | VANGUARD FIDUCIARY#42 · 302,482 sh | 302,482 | $29.5M | <0.01% | +21.1% |
| 43 | DRIEHAUS CAPITAL MANAGEMENT#43 · 295,266 sh | 295,266 | $28.8M | 0.17% | -6.9% |
| 44 | First Turn Management#44 · 285,771 sh | 285,771 | $27.9M | 2.98% | +29.4% |
| 45 | Assenagon Asset Management S.A.#45 · 280,649 sh | 280,649 | $27.4M | — | New |
| 46 | TANG CAPITAL MANAGEMENT#46 · 264,692 sh | 264,692 | $25.8M | 1.17% | 0.0% |
| 47 | Artisan Partners Limited Partnership#47 · 258,269 sh | 258,269 | $25.2M | 0.04% | -32.4% |
| 48 | BANK OF AMERICA#48 · 256,833 sh | 256,833 | $25.0M | <0.01% | +36.0% |
| 49 | Bank of New York Mellon#49 · 256,393 sh | 256,393 | $25.0M | <0.01% | +36.1% |
| 50 | RTW INVESTMENTS#50 · 248,063 sh | 248,063 | $24.2M | 0.21% | 0.0% |
| 51 | EMERALD ADVISERS#51 · 247,805 sh | 247,805 | $24.2M | 0.57% | New |
| 52 | Pictet Asset Management Holding SA#52 · 247,295 sh | 247,295 | $24.1M | 0.02% | +4922.2% |
| 53 | TD ASSET MANAGEMENT#53 · 225,334 sh | 225,334 | $22.0M | 0.02% | +93.3% |
| 54 | EVENTIDE ASSET MANAGEMENT#54 · 225,261 sh | 225,261 | $22.0M | 0.29% | 0.0% |
| 55 | LMR Partners LLP#55 · 223,995 sh | 223,995 | $21.8M | 0.08% | +92.4% |
| 56 | Candriam S.C.A.#56 · 204,214 sh | 204,214 | $19.9M | 0.09% | -4.4% |
| 57 | StemPoint Capital#57 · 200,851 sh | 200,851 | $19.6M | 3.37% | +134.9% |
| 58 | Qube Research & Technologies Ltd#58 · 196,924 sh | 196,924 | $19.2M | 0.02% | +548.8% |
| 59 | SAMLYN CAPITAL#59 · 196,326 sh | 196,326 | $19.1M | 0.31% | -54.5% |
| 60 | Nicholas Investment Partners#60 · 186,769 sh | 186,769 | $18.2M | 1.03% | +264.4% |
| 61 | ADAGE CAPITAL PARTNERS GP, L.L.C.#61 · 185,000 sh | 185,000 | $18.0M | 0.03% | +15.6% |
| 62 | Ensign Peak Advisors#62 · 174,187 sh | 174,187 | $17.0M | 0.03% | -14.8% |
| 63 | TimesSquare Capital Management#63 · 166,357 sh | 166,357 | $16.2M | 0.24% | New |
| 64 | Atika Capital Management#64 · 165,000 sh | 165,000 | $16.1M | 1.06% | +28.1% |
| 65 | Artia Global Partners#65 · 162,990 sh | 162,990 | $15.9M | 2.93% | 0.0% |
| 66 | BALYASNY ASSET MANAGEMENT L.P.#66 · 162,005 sh | 162,005 | $15.8M | 0.02% | -65.8% |
| 67 | Neuberger Berman Group#67 · 157,574 sh | 157,574 | $15.4M | 0.01% | +166.7% |
| 68 | Alyeska Investment Group, L.P.#68 · 150,592 sh | 150,592 | $14.7M | 0.04% | +188.2% |
| 69 | Russell Investments Group, Ltd.#69 · 143,431 sh | 143,431 | $14.0M | 0.01% | +11.1% |
| 70 | Eagle Health Investments#70 · 131,344 sh | 131,344 | $12.8M | 2.12% | New |
| 71 | EMERALD MUTUAL FUND ADVISERS#71 · 131,018 sh | 131,018 | $12.8M | 0.45% | New |
| 72 | MARSHALL WACE, LLP#72 · 128,743 sh | 128,743 | $12.5M | <0.01% | -62.3% |
| 73 | PFM Health Sciences#73 · 121,222 sh | 121,222 | $11.8M | 1.01% | -29.6% |
| 74 | Tri Locum Partners#74 · 120,712 sh | 120,712 | $11.8M | 1.45% | -17.1% |
| 75 | Nuveen#75 · 119,460 sh | 119,460 | $11.6M | <0.01% | -45.1% |
| 76 | ORBIMED ADVISORS#76 · 115,000 sh | 115,000 | $11.2M | 0.21% | New |
| 77 | Patient Square Capital#77 · 108,000 sh | 108,000 | $10.5M | 1.63% | +15.0% |
| 78 | TWO SIGMA INVESTMENTS#78 · 107,455 sh | 107,455 | $10.5M | <0.01% | New |
| 79 | MORGAN STANLEY#79 · 106,376 sh | 106,376 | $10.4M | <0.01% | +9.2% |
| 80 | SEVEN GRAND MANAGERS#80 · 100,000 sh | 100,000 | $9.7M | 0.39% | 0.0% |
| 81 | FIRST ADVISORS#81 · 94,152 sh | 94,152 | $9.2M | <0.01% | New |
| 82 | SEI INVESTMENTS#82 · 92,280 sh | 92,280 | $9.0M | <0.01% | +0.1% |
| 83 | MILLENNIUM MANAGEMENT#83 · 91,838 sh | 91,838 | $9.0M | <0.01% | -64.9% |
| 84 | VICTORY CAPITAL MANAGEMENT#84 · 88,315 sh | 88,315 | $8.6M | <0.01% | +463.9% |
| 85 | AMERICAN CENTURY COMPANIES#85 · 87,860 sh | 87,860 | $8.6M | <0.01% | +11.1% |
| 86 | Rhenman & Partners Asset Management AB#86 · 86,127 sh | 86,127 | $8.4M | 0.79% | +5.5% |
| 87 | Invesco Ltd.#87 · 85,603 sh | 85,603 | $8.3M | <0.01% | -34.5% |
| 88 | UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AME#88 · 75,396 sh | 75,396 | $7.3M | <0.01% | +24.8% |
| 89 | MOODY ALDRICH PARTNERS#89 · 74,552 sh | 74,552 | $7.3M | 1.31% | -9.2% |
| 90 | Swiss National Bank#90 · 73,800 sh | 73,800 | $7.2M | <0.01% | +7.0% |
| 91 | DEUTSCHE BANK AG\#91 · 69,756 sh | 69,756 | $6.8M | <0.01% | +121.7% |
| 92 | MERCER GLOBAL ADVISORS#92 · 65,683 sh | 65,683 | $6.4M | <0.01% | New |
| 93 | LPL Financial#93 · 65,295 sh | 65,295 | $6.4M | <0.01% | +59.9% |
| 94 | Seven Fleet Capital Management#94 · 64,723 sh | 64,723 | $6.3M | 1.04% | +19.3% |
| 95 | SummitTX Capital, L.P.#95 · 63,866 sh | 63,866 | $6.2M | 0.16% | -36.2% |
| 96 | MANUFACTURERS LIFE INSURANCE COMPANY, THE#96 · 62,829 sh | 62,829 | $6.1M | <0.01% | -3.7% |
| 97 | NEW YORK STATE COMMON RETIREMENT FUND#97 · 60,048 sh | 60,048 | $5.9M | <0.01% | +25.2% |
| 98 | Sio Capital Management#98 · 59,254 sh | 59,254 | $5.8M | 0.96% | -84.0% |
| 99 | RHUMBLINE ADVISERS#99 · 58,521 sh | 58,521 | $5.7M | <0.01% | +29.5% |
| 100 | Jones Hill Capital#100 · 57,100 sh | 57,100 | $5.6M | 1.18% | New |
Funds that sold out of DNTH in Q2 2026 (32)
Held DNTH at the end of Q1 2026 and filed a Q2 2026 13F without it. Not in the list above, because they no longer hold it. Largest prior position first.
Source: Form 13F-HR filings on SEC EDGAR, Q2 2026. Values are as reported by each manager at quarter end. “% of portfolio” is the position’s share of the manager’s total reported 13F value for the same quarter. “New” means the manager filed a 13F for Q1 2026 without this position; a dash means no comparison is available. Where a manager’s own filing is internally inconsistent its value is withheld and it is listed last. 13F data shows reported holdings, not recommendations.